{
    "organizations": [],
    "uuid": "6f14e1384f406e1c166862486c9b6a20da372c7a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bioverativ-q4-revenue-rose-283-per/brief-bioverativ-q4-revenue-rose-28-3-percent-to-328-7-million-idUSASB0C5IE",
    "ord_in_thread": 0,
    "title": "Bioverativ Q4 Revenue Rose 28.3 Percent To $328.7 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 13 (Reuters) - Bioverativ Inc:\n* BIOVERATIV REPORTS FOURTH QUARTER AND FULL YEAR 2017 PERFORMANCE\n* Q4 REVENUE ROSE 28.3 PERCENT TO $328.7 MILLION * QTRLY ‍SHR $1.30​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-14T05:24:00.000+02:00",
    "crawled": "2018-02-14T12:52:33.020+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "bioverativ",
        "inc",
        "bioverativ",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "performance",
        "q4",
        "revenue",
        "rose",
        "percent",
        "million",
        "qtrly",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}